metaBIX Biotech
PrivateLast Round
Early Funding
Mar 13, 2026
Total Funding Raised
$1.3M
Company Overview
metaBIX Biotech is a biotechnology company that provides an environmental biosurveillance platform using artificial intelligence to predict and prevent disease outbreaks in animal production.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Biotechnology, Medical AI, Environmental Monitoring
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
metaBIX Biotech Comps
Public and private peers based on sector, stage, and business model.
metaBIX Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 13, 2026 |
metaBIX Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Danta Fund | Early Funding |
| Angel Hub | Early Funding |
| EWA Capital | Early Funding |
| AIR Capital | Early Funding |
| Agencia Nacional de Investigación e Innovación | Early Funding |
| TheBoard Peru | Early Funding |
| Dalus Capital | Early Funding |
metaBIX Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about metaBIX Biotech's valuation, stock price, and market status.